אינג'י 10 מג40 מג טבליות ישראל - עברית - Ministry of Health

אינג'י 10 מג40 מג טבליות

merck sharp & dohme israel ltd - ezetimibe; simvastatin - טבליה - ezetimibe 10 mg; simvastatin 40 mg - simvastatin - simvastatin - hypercholesterolemia: inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. inegy contains ezetimibe and simvastatin. simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. homozygous familial hypercholesterolemia (hofh): inegy is indicated as adjunctive therapy to diet for use in patients with hofh. patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [ldl] apheresis).

אינג'י 10 מג80 מג טבליות ישראל - עברית - Ministry of Health

אינג'י 10 מג80 מג טבליות

merck sharp & dohme israel ltd - ezetimibe; simvastatin - טבליה - ezetimibe 10 mg; simvastatin 80 mg - simvastatin - simvastatin - hypercholesterolemia: inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. inegy contains ezetimibe and simvastatin. simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. homozygous familial hypercholesterolemia (hofh): inegy is indicated as adjunctive therapy to diet for use in patients with hofh. patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [ldl] apheresis).

פרוברה 100 מ"ג ישראל - עברית - Ministry of Health

פרוברה 100 מ"ג

pfizer pharmaceuticals israel ltd - medroxyprogesterone acetate 100 mg - tablets - medroxyprogesterone - progestogen indicated for the treatment of certain hormone dependent neoplasms.

סוטנט 37.5 מ"ג ישראל - עברית - Ministry of Health

סוטנט 37.5 מ"ג

pfizer pharmaceuticals israel ltd - sunitinib as malate 37.5 mg - capsules - sunitinib - sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sutent is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.

אסטרציט ישראל - עברית - Ministry of Health

אסטרציט

pfizer pharmaceuticals israel ltd - estramustine phosphate 140 mg - capsules - estramustine - second line therapy in prostatic carcinoma in advanced stages.

דוסטינקס ישראל - עברית - Ministry of Health

דוסטינקס

pfizer pfe pharmaceuticals israel ltd - cabergoline - טבליה - cabergoline 0.5 mg - cabergoline - cabergoline - treatment of hyperprolactinemic disorders.dostinex is indicated for the treatment of dysfunctions associated with hyperprolactinemia, including amenorrhea, oligomenorrhea, anovulation and galactorrhea. dostinex is indicated in patients with prolactin-secreting pituitary adenomas (micro-and macroprolactinomas), idiopathic hyperprolactinemia, or empty sella syndrome with associated hyperprolactinemia. inhibition and supression of lactation .

קבאסר 1 מ"ג ישראל - עברית - Ministry of Health

קבאסר 1 מ"ג

pfizer pharmaceuticals israel ltd - cabergoline 1 mg - tablets - cabergoline - parkinson's disease. combination therapy with l-dopa and as monotherapy for newly diagnosed illness.

קבאסר 2 מ"ג ישראל - עברית - Ministry of Health

קבאסר 2 מ"ג

pfizer pharmaceuticals israel ltd - cabergoline 2 mg - tablets - cabergoline - parkinson's disease. combination therapy with l-dopa and as monotherapy for newly diagnosed illness.

קסנאקס 0.5 מג XR ישראל - עברית - Ministry of Health

קסנאקס 0.5 מג xr

pfizer pfe pharmaceuticals israel ltd - alprazolam - טבליות עם שחרור מושהה - alprazolam 0.5 mg - alprazolam - alprazolam - for the management of anxiety and anxiety associated with depression.treatment of panic disorder with or without phobic avoidance

קסנאקס 1 מג XR ישראל - עברית - Ministry of Health

קסנאקס 1 מג xr

pfizer pfe pharmaceuticals israel ltd - alprazolam - טבליות עם שחרור מושהה - alprazolam 1 mg - alprazolam - alprazolam - for the treatment of anxiety and anxiety associated with depression. treatment of panic disorder with or without phobic avoidance